The first proposal “Expansion of induction of buprenorphine via telemedicine encounter” can be found here. The second proposed rule “Telemedicine Prescribing of Controlled Substances when the Practitioner and the Patient have not had a Prior In-person Medical Evaluation” can be found here.
NPRM comment period ends March 31, 2023 .
Additional resources for patients can be found here:
- Is My Prescription a Controlled Medication? Controlled-Non Controlled List (dea.gov)
- Can My Medication be Prescribed through Telemedicine? Controlled Substance Guidance (dea.gov)
Additional resources for practitioners can be found here:
- Proposed Rules Summary Telemedicine Rules Summary.pdf (dea.gov)
- Proposed Rules Highlights for Medical Practitioners Telehealth Highlights Medical Practitioners.pdf (dea.gov)
For more information on the DEA’s continued efforts to expand access to medications used in treatment for those suffering from opioid use disorder visit here.